These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 26455952)
41. Presenilin 1 Regulates Membrane Homeostatic Pathways that are Dysregulated in Alzheimer's Disease. Deaton CA; Johnson GVW J Alzheimers Dis; 2020; 77(3):961-977. PubMed ID: 32804090 [TBL] [Abstract][Full Text] [Related]
42. Presenilins as endoplasmic reticulum calcium leak channels and Alzheimer's disease pathogenesis. Supnet C; Bezprozvanny I Sci China Life Sci; 2011 Aug; 54(8):744-51. PubMed ID: 21786197 [TBL] [Abstract][Full Text] [Related]
43. Nitric oxide signaling is recruited as a compensatory mechanism for sustaining synaptic plasticity in Alzheimer's disease mice. Chakroborty S; Kim J; Schneider C; West AR; Stutzmann GE J Neurosci; 2015 Apr; 35(17):6893-902. PubMed ID: 25926464 [TBL] [Abstract][Full Text] [Related]
44. Modulation of synaptic plasticity and Tau phosphorylation by wild-type and mutant presenilin1. Dewachter I; Ris L; Croes S; Borghgraef P; Devijver H; Voets T; Nilius B; Godaux E; Van Leuven F Neurobiol Aging; 2008 May; 29(5):639-52. PubMed ID: 17222948 [TBL] [Abstract][Full Text] [Related]
45. L-Stepholidine rescues memory deficit and synaptic plasticity in models of Alzheimer's disease via activating dopamine D1 receptor/PKA signaling pathway. Hao JR; Sun N; Lei L; Li XY; Yao B; Sun K; Hu R; Zhang X; Shi XD; Gao C Cell Death Dis; 2015 Nov; 6(11):e1965. PubMed ID: 26539912 [TBL] [Abstract][Full Text] [Related]
46. Network compensation of cyclic GMP-dependent protein kinase II knockout in the hippocampus by Ca2+-permeable AMPA receptors. Kim S; Titcombe RF; Zhang H; Khatri L; Girma HK; Hofmann F; Arancio O; Ziff EB Proc Natl Acad Sci U S A; 2015 Mar; 112(10):3122-7. PubMed ID: 25713349 [TBL] [Abstract][Full Text] [Related]
47. The Ca(2+) channel inhibitor 2-APB reverses β-amyloid-induced LTP deficit in hippocampus by blocking BAX and caspase-3 hyperactivation. Hu WY; He ZY; Yang LJ; Zhang M; Xing D; Xiao ZC Br J Pharmacol; 2015 May; 172(9):2273-85. PubMed ID: 25521332 [TBL] [Abstract][Full Text] [Related]
50. Calcineurin inhibition rescues early synaptic plasticity deficits in a mouse model of Alzheimer's disease. Cavallucci V; Berretta N; Nobili A; Nisticò R; Mercuri NB; D'Amelio M Neuromolecular Med; 2013 Sep; 15(3):541-8. PubMed ID: 23821337 [TBL] [Abstract][Full Text] [Related]
51. Monoamine oxidase-A physically interacts with presenilin-1(M146V) in the mouse cortex. Wei Z; Gabriel GG; Rui L; Cao X; Pennington PR; Chlan-Fourney J; Nazarali AJ; Baker GB; Mousseau DD J Alzheimers Dis; 2012; 28(2):403-22. PubMed ID: 22045496 [TBL] [Abstract][Full Text] [Related]
52. Defects of immune regulation in the presenilin-1 mutant knockin mouse. Morgan GA; Guo Q; Chan SL; Gary DS; Osborne BA; Mattson MP Neuromolecular Med; 2007; 9(1):35-45. PubMed ID: 17114823 [TBL] [Abstract][Full Text] [Related]
53. Convergence of presenilin- and tau-mediated pathways on axonal trafficking and neuronal function. Peethumnongsin E; Yang L; Kallhoff-Muñoz V; Hu L; Takashima A; Pautler RG; Zheng H J Neurosci; 2010 Oct; 30(40):13409-18. PubMed ID: 20926667 [TBL] [Abstract][Full Text] [Related]
54. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Guo Q; Fu W; Sopher BL; Miller MW; Ware CB; Martin GM; Mattson MP Nat Med; 1999 Jan; 5(1):101-6. PubMed ID: 9883847 [TBL] [Abstract][Full Text] [Related]
55. Early changes in hippocampal Eph receptors precede the onset of memory decline in mouse models of Alzheimer's disease. Simón AM; de Maturana RL; Ricobaraza A; Escribano L; Schiapparelli L; Cuadrado-Tejedor M; Pérez-Mediavilla A; Avila J; Del Río J; Frechilla D J Alzheimers Dis; 2009; 17(4):773-86. PubMed ID: 19542617 [TBL] [Abstract][Full Text] [Related]
56. The presenilin 1 mutation (M146V) linked to familial Alzheimer's disease attenuates the neuronal differentiation of NTera 2 cells. Tokuhiro S; Tomita T; Iwata H; Kosaka T; Saido TC; Maruyama K; Iwatsubo T Biochem Biophys Res Commun; 1998 Mar; 244(3):751-5. PubMed ID: 9535737 [TBL] [Abstract][Full Text] [Related]
57. Dietary restriction protects hippocampal neurons against the death-promoting action of a presenilin-1 mutation. Zhu H; Guo Q; Mattson MP Brain Res; 1999 Sep; 842(1):224-9. PubMed ID: 10526115 [TBL] [Abstract][Full Text] [Related]
58. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model. Faivre E; Hölscher C J Alzheimers Dis; 2013; 35(2):267-83. PubMed ID: 23568101 [TBL] [Abstract][Full Text] [Related]
59. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. Chan SL; Mayne M; Holden CP; Geiger JD; Mattson MP J Biol Chem; 2000 Jun; 275(24):18195-200. PubMed ID: 10764737 [TBL] [Abstract][Full Text] [Related]
60. Lysosomal alkalization and dysfunction in human fibroblasts with the Alzheimer's disease-linked presenilin 1 A246E mutation can be reversed with cAMP. Coffey EE; Beckel JM; Laties AM; Mitchell CH Neuroscience; 2014 Mar; 263():111-24. PubMed ID: 24418614 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]